NASDAQ:CAPR

Capricor Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy CAPR

*Your capital is at risk

$27.64

+0.300 (+1.10%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CAPR Prediction Chart

CAPR Predictions History

Latest community submissions for CAPR.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
JS Pro	Oct 2, 2017	$2.77 -91.97%	$3.45	V	80.30%
mitch.bagdigian.10816 Amateur	Oct 2, 2017	$3.29 -90.46%	$3.45	X	95.40%
JS Pro	Sep 20, 2017	$1.97 -90.30%	$2.03	V	97.00%
Victor..Li.8930 Merchant	Jul 24, 2017	$1.33 -88.13%	$1.12	X	81.30%
JS Pro	Jul 19, 2017	$1.21 -89.57%	$1.16	V	95.70%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CAPR with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CAPRICOR THERAPEUTICS

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by